Multidisciplinary care pathway tailored on frailty in cancer patients referred to outpatient palliative care.
Phase: Non-pharmacological interventional studies
Principal Investigator: Dott. Massa Giacomo
Main Facility: Cure Palliative, Terapia del Dolore e Riabilitazione
Patient-Reported Outcome Measures (PROMs) can identify which symptoms or needs most significantly affect patients, helping to direct care toward the vulnerabilities (psychological, physical, socioeconomic, nutritional, spiritual) that require the most attention. Palliative care can be tailored based on the vulnerabilities identified by PROMs at the time of the patient’s initial assessment.
Mistral is a single-center, interventional, randomized, open-label study in which the experimental group will be enrolled in a more strictly structured palliative care pathway, based on the PROMs assessed at the initial visit. The control group will receive standard palliative care, as determined by the investigator.
The primary objective of this study is to demonstrate the superiority, in terms of clinical outcomes, of a structured intervention based on the PROMs recorded at baseline.
The study endpoints include a reduction in symptom burden, measured using the Total Symptom Distress Score (TSDS) derived from the Edmonton Symptoms Assessment Scale (ESAS), and a reduction in general distress, measured using the Distress Thermometer (DT) score.
Last update: 12/05/2026